Literature DB >> 8465812

Mechanisms of proteinuria in noninflammatory glomerular diseases.

V J Savin1.   

Abstract

Neither the initiating factors nor the proximate causes of injury that produce proteinuria in nephrotic syndrome have been clearly defined. Immune mechanisms have been postulated in minimal-change nephrotic syndrome (MCNS), focal segmental glomerular sclerosis (FSGS), and glomerular sclerosis associated with human immunodeficiency virus (HIV) infection. Circulating factors have been proposed in MCNS and FSGS, although no specific mediator has been identified. Prompt remission of proteinuria following steroid treatment and the presence of altered immune responsiveness in patients with MCNS have been used to support the participation of an immune mechanism in the pathogenesis of MCNS. Both FSGS and HIV-related nephropathy are usually steroid-resistant. Immune mechanisms are postulated in FSGS because of early recurrence after transplantation, and in HIV-related nephropathy because of the numerous associated immune abnormalities. Experimental models of nephrotic syndrome based on neutralization of glomerular charge, toxic injury to podocytes, injection of antibodies to glomerular components, or abnormalities in transgenic mice have been used to define mechanisms of glomerular injury. This review summarizes physiologic and immunologic abnormalities in MCNS, FSGS, and HIV-associated nephropathy and in several experimental models of nephrotic syndrome, and outlines the immunologic mechanisms and cellular reactions that may be responsible for glomerular dysfunction in these entities.

Entities:  

Mesh:

Year:  1993        PMID: 8465812     DOI: 10.1016/s0272-6386(12)80260-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome.

Authors:  Huseyin Begenik; Yasemin Usul Soyoral; Reha Erkoc; Habib Emre; Abdullah Taskın; Mehmet Tasdemir; Mehmet Aslan
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

2.  Altered activity of plasma hemopexin in patients with minimal change disease in relapse.

Authors:  Winston W Bakker; Catharina M L van Dael; Leonie J W M Pierik; Joanna A E van Wijk; Jeroen Nauta; Theo Borghuis; Jola J Kapojos
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

Review 3.  Mediation of immune glomerular injury.

Authors:  W G Couser
Journal:  Clin Investig       Date:  1993-10

Review 4.  New insights into mechanisms of immune glomerular injury.

Authors:  W G Couser
Journal:  West J Med       Date:  1994-05

5.  IgA nephropathy with minimal change disease.

Authors:  Leal C Herlitz; Andrew S Bomback; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

6.  T cells and macrophages in Trypanosoma brucei-related glomerulopathy.

Authors:  M L van Velthuysen; A E Mayen; N van Rooijen; G J Fleuren; E de Heer; J A Bruijn
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 7.  Focal segmental glomerulosclerosis.

Authors:  I Ichikawa; A Fogo
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 8.  Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis.

Authors:  M R First
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

9.  Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?

Authors:  A Rybi-Szumińska; A Wasilewska; J Michaluk-Skutnik; B Osipiuk-Remża; R Fiłonowicz; M Zając
Journal:  Ir J Med Sci       Date:  2014-07-24       Impact factor: 1.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.